Phase II study of cadonilimab monotherapy for recurrent small cell neuroendocrine carcinoma of the cervix
Year: 2026
Type: article
Source: Gynecologic Oncology
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7128919805
